Fumonisin B1-13C34
Based on 1 Customer Validation
Fumonisin B1-13C34 is the 13C labeled Fumonisin B1 (HY-N6719). Fumonisin B1 is a mycotoxin produced from Fusarium moniliforme. Fumonisin B1 is a potent inhibitor of sphingosine N-acyltransferase (ceramide synthase) and disrupts de novo sphingolipid biosynthesis. Fumonisin B1 is the most abundant and toxic fumonisin.
The product specifications provided below refer solely to the active content of Fumonisin B1-13C34.
For research use only. We do not sell to patients.
- Purity : 98.5%
- CAS No.: 1217458-62-2
- Formula: 13C34H59NO15
- Molecular Weight:755.58
-
Storage:
Solution, -20°C, 2 years
To place orders, for customer services and technical support, please contact: MedChemExpress USA
Tel: 609-228-6898 E-mail: [email protected] [email protected]
-
Biological Activity
-
Chemical Information
- Purity & Documentation
- References
-
Help & FAQs
-
HY-A0183
PhosphatidylserineAnti-Inflammatory/Immunosuppressive Signal -
HY-W040255
1-Palmitoyl-2-glutaryl-sn-glycero-3-phosphocholineOxidized Phospholipid -
HY-111954
(+)-Erinacin AAnticancer Agent -
HY-125348S
6α-Hydroxy paclitaxel-d5Stable?Isotope -
HY-137936
Terrecyclic AcidSesquiterpene -
HY-15296S1
Cabergoline-d6Stable Isotope -
HY-N8331
Terpendole IACAT Inhibitor -
HY-N11989
Nanangenine BFungal Metabolite -
HY-152021S
C18 Ceramide-1-phosphate (d18:1/18:0)-d3 -
HY-W013061S
(S)-Propane-1,2,3-triyl tripalmitate-d9Stable Isotope
Biological Activity
Description
The product specifications provided below refer solely to the active content of Fumonisin B1-13C34.
IC50 & Target
Sphingosine N-acyltransferase[2]
In Vitro
Stable heavy isotopes of hydrogen, carbon, and other elements have been incorporated into drug molecules, largely as tracers for quantitation during the drug development process. Deuteration has gained attention because of its potential to affect the pharmacokinetic and metabolic profiles of drugs[1].
Fumonisin B1 alters the gene expression and signal transduction pathways in monkey kidney cells[2].
Fumonisin B1 increases the initial disruption of sphingolipid metabolism and the accumulation of sphinganine in LLC-PK1 kidney cells, causes DNA damage of apoptotic type in rat astrocytes[2].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
Application
1. This compound can be used as a tracer
2. This compound can be used as an internal standard for quantitative analysis by NMR, GC-MS, or LC-MS.
Chemical Information
-
CAS No. 1217458-62-2
-
Unlabeled CAS 116355-83-0
-
Appearance Liquid
-
Molecular Weight 755.58
-
Formula 13C34H59NO15
-
Color Colorless to light yellow
-
SMILES
O[13C]([13CH2][13C@@H]([13C](O)=O)[13CH2][13C](O[13C@@H]([13CH2][13C@@H]([13CH3])[13CH2][13C@H](O)[13CH2][13CH2][13CH2][13CH2][13C@@H](O)[13CH2][13C@H](O)[13C@@H](N)[13CH3])[13C@@H]([13C@H]([13CH3])[13CH2][13CH2][13CH2][13CH3])O[13C]([13CH2][13C@H]([13C](O)=O)[13CH2][13C](O)=O)=O)=O)=O
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Solution, -20°C, 2 years
Purity & Documentation
-
Data Sheet (292 KB)
-
SDS (419 KB)
- English - EN (419 KB)
- Français - FR (419 KB)
- Deutsch - DE (419 KB)
- Norwegian - NO (419 KB)
- Español - ES (419 KB)
- Swedish - SV (419 KB)
- Italian - IT (419 KB)
- Korean - KR (419 KB)
- Portuguese - PT (419 KB)
-
Handling Instructions (2659 KB)
References
[1]. Russak EM, et al. Impact of Deuterium Substitution on the Pharmacokinetics of Pharmaceuticals. Ann Pharmacother. 2019 Feb;53(2):211-220. [Content Brief]
[2]. Henry MH, et al. The toxicity of fumonisin B1, B2, and B3, individually and in combination, in chicken embryos. Poult Sci. 2001 Apr;80(4):401-7. [Content Brief]
[3]. Wang SK, et al. Effect of fumonisin B₁ on the cell cycle of normal human liver cells. Mol Med Rep. 2013 Jun;7(6):1970-6. [Content Brief]
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
Fumonisin B1-13C34 Related Classifications
HY-N6719S Related Classifications
Powered by Bioz